PHAT EPS Estimates
Phathom Pharmaceuticals, Inc.
$7.40
+$0.40(+5.71%)
34
Overall
40
Value
18
Tech
44
Quality
Market Cap
$598.67M
Volume
1.72M
52W Range
$6.52 - $18.31
Target Price
$20.45
PHAT EPS estimates: the consensus estimate for Phathom Pharmaceuticals, Inc.'s current fiscal year is -$0.27 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PHAT EPS Estimates
- EPS estimate, current quarter
- $-0.01
- EPS estimate, next quarter
- $0.07
- EPS estimate, current year
- $-0.27
- EPS estimate, next year
- $1.16
- EPS growth, 3-year
- +15.66%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.03 |
| 2024 | $-5.29 |
| 2023 | $-3.93 |
| 2022 | $-5.05 |
| 2021 | $-3.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $7.40 | +5.7% | 1.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW